Clinical Trials & Translational Research Advisory Committee (CTAC)
CTAC provides broad scientific and programmatic advice on the investment of taxpayer dollars in clinical trials and translational research across NCI. The goal is to foster an open, collaborative system, involving all the critical stakeholders, that is integrated and efficient, yet innovative and responsive enough to move discoveries to benefit cancer patients in a timely manner.
More About CTAC
-
Meetings
Get information about Clinical Trials & Translational Research Advisory Committee meetings.
-
Members
Find out who serves on NCI's Clinical Trials & Translational Research Advisory Committee.
-
Charter
Learn about member selection, meeting format, and duties of CTAC.
-
CTAC Working Groups
Working groups participants include CTAC members and experts from the scientific community.
-
Subcommittees
Subcommittees, comprised of CTAC members, advise the full board on a variety of topics.
-
Division of Extramural Activities
DEA coordinates scientific review of proposed extramural research and conducts analysis of funded research.
Contact
Division of Extramural Activities
National Cancer Institute
9609 Medical Center Drive
West Tower, 7th Floor
Rockville, MD 20850
Bethesda, MD 20892-9750 (US Postal Address)
DEA Director's Office Direct Number: 240-276-6340
Committee Management Office Direct Number: 240-276-6420
Email: rawler@mail.nih.gov